Intra-Uterine Contraceptive Devices Market Forecast 2024 Leading in Global Industry by Top Most Players - Bayer AG, Teva Pharmaceuticals Industries Ltd., Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna Interna

The Market of Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024

Key Drivers: Global Intra-Uterine Contraceptive Devices

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

The growing rate of unintended pregnancies has aided the increase in the adoption of contraceptive methods which is expected to drive the growth of the IUCD market.

The rising number of initiatives to promote the use of intra uterine contraceptive devices acts as a significant driver for this market.

Growing awareness of contraceptive one of the factors contributing to the growth of the market in Europe.

Inquiry Before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market

Key Points: Global Intra-Uterine Contraceptive Devices Market

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed.

Copper IUD market is growing with the highest CAGR.

Globally HormonalIUD is driving the market with highest market share. However, Copper IUD is growing with highest CAGR.

North America is dominating the intra-uterine contraceptive devices market.

Market Segmentation: Global Intra-Uterine Contraceptive Devices

The Global Intra-Uterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

View Full Report Visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

Table of Contents:

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES
3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
3.1.3. FAVOURABLE INSURANCE FOR IUCD’S
3.1.4. GROWING AWARENESS OF CONTRACEPTIVE
3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
3.1.6. TECHNOLOGICAL ADVANCEMENTS

3.2. RESTRAINTS

3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
3.2.4. CHANGES IN GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.2. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.2.1. U.S. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.2.2. CANADA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.2.3. MEXICO INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.3. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.3.1. GERMANY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.2. FRANCE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.3. ITALY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.4. U.K. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.5. SWITZERLAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.6. NETHERLANDS INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.7. SPAIN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.8. RUSSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.9. BELGIUM INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.10. TURKEY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.4. APAC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.4.1. CHINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.2. SOUTH KOREA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.3. JAPAN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.4. INDIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.5. THAILAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.6. SINGAPORE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.7. MALAYSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.8. PHILIPPINES INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.9. AUSTRALIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.10. INDONESIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.5. SOUTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

7.5.1. BRAZIL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.2. COLOMBIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.3. ARGENTINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.4. CHILE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.5. ECUADOR INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.6. URUGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.7. PARAGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES
7.5.8. PERU INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.9. BOLIVIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6. MEA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6.1. EGYPT INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6.2. SAUDI ARABIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

8.1. COMPANY SHARE ANALYSIS: GLOBAL
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

9. COMPANY PROFILES

9.1. BAYER AG

9.1.1. COMPANY OVERVIEW
9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.1.3. REVENUE ANALYSIS
9.1.4. PRODUCT PORTFOLIO
9.1.5. RECENT DEVELOPMENTS
9.1.6. DATA BRIDGE ANALYSIS

9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

9.2.1. COMPANY OVERVIEW
9.2.2. REVENUE ANALYSIS
9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.2.4. PRODUCT PORTFOLIO
9.2.5. RECENT DEVELOPMENTS
9.2.6. DATA BRIDGE ANALYSIS

9.3. ALLERGEN PLC

9.3.1. COMPANY OVERVIEW
9.3.2. REVENUE ANALYSIS
9.3.3. PRODUCT PORTFOLIO
9.3.4. RECENT DEVELOPMENTS
9.3.5. DATA BRIDGE ANALYSIS

9.4. DKT INTERNATIONAL

9.4.1. COMPANY OVERVIEW
9.4.2. REVENUE ANALYSIS
9.4.3. PRODUCT PORTFOLIO

9.5. SMB CORPORATION

9.5.1. COMPANY OVERVIEW
9.5.2. REVENUE ANALYSIS
9.5.3. PRODUCT PORTFOLIO
9.5.4. RECENT DEVELOPMENTS
9.5.5. DATA BRIDGE ANALYSIS

9.6. OCON MEDICAL LTD.

9.6.1. COMPANY OVERVIEW
9.6.2. REVENUE ANALYSIS
9.6.3. PRODUCT PORTFOLIO
9.6.4. RECENT DEVELOPMENTS
9.6.5. DATA BRIDGE ANALYSIS

9.7. MONA LISA N.V.

9.7.1. COMPANY OVERVIEW
9.7.2. REVENUE ANALYSIS
9.7.3. PRODUCT PORTFOLIO
9.7.4. RECENT DEVELOPMENTS

9.8. MEDISAFE DISTRIBUTION INC.

9.8.1. COMPANY OVERVIEW
9.8.2. REVENUE ANALYSIS
9.8.3. PRODUCT PORTFOLIO
9.8.4. RECENT DEVELOPMENTS

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.